Wang Shengnan, Jin Zihui, Wu Biyu, Morris Andrew J, Deng Pan
Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences and Central Arkansas Veterans Affairs Healthcare System, Little Rock, Arkansas, USA.
J Lipid Res. 2025 Jan;66(1):100726. doi: 10.1016/j.jlr.2024.100726. Epub 2024 Dec 10.
Ceramides are important intermediates in sphingolipid metabolism and serve as signaling molecules with independent biological significance. Elevated cellular and circulating ceramide levels are consistently associated with pathological conditions including cardiometabolic diseases, neurological diseases, autoimmune diseases, and cancers. Although pharmacological inhibition of ceramide formation often protects against these diseases in animal models, pharmacological modulation of ceramides in humans remains impractical. Dietary interventions including the Mediterranean diet, lacto-ovo-vegetarian diet, calorie-restricted diet, restriction of dairy product consumption, and dietary supplementation with polyunsaturated fatty acids, dietary fibers, and polyphenols, all have beneficial effects on modulating ceramide levels. Mechanistic insights into these interventions are discussed. This article reviews the relationships between ceramides and disease pathogenesis, with a focus on dietary intervention as a viable strategy for lowering the concentration of circulating ceramides.
神经酰胺是鞘脂代谢的重要中间体,并作为具有独立生物学意义的信号分子。细胞内和循环中的神经酰胺水平升高一直与包括心脏代谢疾病、神经疾病、自身免疫性疾病和癌症在内的病理状况相关。尽管在动物模型中,对神经酰胺形成的药理学抑制通常能预防这些疾病,但在人类中对神经酰胺进行药理学调节仍不切实际。包括地中海饮食、蛋奶素食饮食、热量限制饮食、限制乳制品消费以及多不饱和脂肪酸、膳食纤维和多酚的膳食补充在内的饮食干预,均对调节神经酰胺水平具有有益作用。本文讨论了这些干预措施的作用机制。本文综述了神经酰胺与疾病发病机制之间的关系,重点关注饮食干预作为降低循环神经酰胺浓度的可行策略。